當(dāng)前位置：首頁 JCRQ1 期刊介紹(非官網(wǎng))

Annals Of Clinical Microbiology And AntimicrobialsSCIE

國際簡稱：ANN CLIN MICROB ANTI 參考譯名：臨床微生物學(xué)和抗菌劑年鑒

中科院分區(qū)
2區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：1476-0711; E-ISSN：1476-0711; 是否OA：開放; 是否預(yù)警：否; TOP期刊：是

出版信息：: 出版地區(qū)：ENGLAND; 出版商：BioMed Central; 出版語言：English; 出版周期：1 issue/year; 出版年份：2002; 研究方向：MICROBIOLOGY

評價信息：: 影響因子：4.6; H-index：45; CiteScore指數(shù)：8.6; SJR指數(shù)：1.19; SNIP指數(shù)：1.413

發(fā)文數(shù)據(jù)：: Gold OA文章占比：100.00%; 研究類文章占比：89.52%; 年發(fā)文量：105; 自引率：0; 開源占比：1; 出版撤稿占比：0; 出版國人文章占比：0.14; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Annals Of Clinical Microbiology And Antimicrobials期刊介紹

Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance. Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases.

Annals of Clinical Microbiology and Antimicrobials is an open access, peer-reviewed journal focusing on information concerning clinical microbiology, infectious diseases and antimicrobials. The management of infectious disease is dependent on correct diagnosis and appropriate antimicrobial treatment, and with this in mind, the journal aims to improve the communication between laboratory and clinical science in the field of clinical microbiology and antimicrobial treatment. Furthermore, the journal has no restrictions on space or access; this ensures that the journal can reach the widest possible audience.

期刊簡介Annals Of Clinical Microbiology And Antimicrobials期刊介紹

《Annals Of Clinical Microbiology And Antimicrobials》自2002出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學(xué)領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間： 12周，或約稿
國際TOP期刊
醫(yī)學(xué)
MICROBIOLOGY
SCIE
中科院2區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Annals Of Clinical Microbiology And Antimicrobials Cite Score數(shù)據(jù)

CiteScore：8.6
SJR：1.19
SNIP：1.413

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Infectious Diseases	Q1	60 / 344	82%
大類：Medicine 小類：Microbiology (medical)	Q1	30 / 140	78%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Annals Of Clinical Microbiology And Antimicrobials 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	2區(qū)	MICROBIOLOGY 微生物學(xué)	2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Annals Of Clinical Microbiology And Antimicrobials JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MICROBIOLOGY	SCIE	Q1	37 / 161	77.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MICROBIOLOGY	SCIE	Q2	56 / 161	65.53%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻質(zhì)量進行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND30
USA13
Japan12
Colombia10
Ethiopia10
India10
Saudi Arabia8
South Korea8
Iran7
Nepal7

本刊中國學(xué)者近年發(fā)表論文

1、Application of next-generation sequencing on diagnosis of bloodstream infection caused by Mycoplasma hominis in a patient with ANCA-associated vasculitis
Author: Chen, Yili; Chen, Hengxin; Huang, Hao; Zhong, Yinyin; Lin, Xiaoshu; Chen, Peisong; Liao, Kang; Yang, Juhua; Liu, Min; Hong, Mengzhi; Wang, Ruizhi

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00580-4
2、Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization
Author: Chen, Xia; Wen, Ximao; Jiang, Zhiping; Yan, Qun

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00554-6
3、The alteration of intrauterine microbiota in chronic endometritis patients based on 16S rRNA sequencing analysis
Author: Chen, Qing; Zhang, Xiaowei; Hu, Qicai; Zhang, Wei; Xie, Yi; Wei, Weixia

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00556-4
4、Maternal colonization with group B Streptococcus and antibiotic resistance in China: systematic review and meta-analyses
Author: Wang, Jing; Zhang, Yan; Lin, Miao; Bao, Junfeng; Wang, Gaoying; Dong, Ruirui; Zou, Ping; Chen, Yuejuan; Li, Na; Zhang, Ting; Su, Zhaoliang; Pan, Xiuzhen

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00553-7
5、Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii Pneumonia in critically pediatric patients
Author: Chen, Hengxin; Liang, Yujian; Wang, Ruizhi; Wu, Yijie; Zhang, Xiaoyun; Huang, Hao; Yu, Xuegao; Hong, Mengzhi; Yang, Juhua; Liao, Kang; Xu, Hongxu; Liu, Min; Chen, Peisong; Chen, Yili

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00555-5
6、CRISPR/Cas12a-based assay for the rapid and high-sensitivity detection of Streptococcus agalactiae colonization in pregnant women with premature rupture of membrane
Author: Yu, Donghong; Liang, Bin; Xu, Haipo; Chen, Lu; Ye, Zhoujie; Wu, Zhihui; Wang, Xinrui

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00558-2
7、Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease
Author: Tian, Fangbing; Li, Yin; Wang, Yue; Yu, Bing; Song, Jianxin; Ning, Qin; Jian, Cui; Ni, Ming

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00560-8
8、Emergence and clonal dissemination of KPC-3-producing Pseudomonas aeruginosa in China with an IncP-2 megaplasmid
Author: Ge, Haoyu; Qiao, Jie; Zheng, Jiahao; Xu, Hao; Liu, Ruishan; Zhao, Junhui; Chen, Ruyan; Li, Chenyu; Guo, Xiaobing; Zheng, Beiwen

Journal: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12941-023-00577-z